We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Takes EU Trial Transparency Complaints to U.S. Trade Chief
PhRMA Takes EU Trial Transparency Complaints to U.S. Trade Chief
February 13, 2014
PhRMA wants the Office of the United States Trade Representative (USTR) to sanction the EU for its plans to publish clinical trial data currently treated as confidential.